- Dose-based pricing goes up as you titrate to higher doses — common with GLP-1 programs.
- Flat-rate pricing stays the same across the dose range, so a higher dose doesn't mean a higher bill.
- Compare the cost at your likely maintenance dose, not just the intro price.
How titration changes the math
GLP-1 treatment usually starts low and steps up over weeks or months to a maintenance dose. Under dose-based pricing, each step up can raise your monthly cost — so the price you see at the start may not be the price you pay at month six or twelve. Under flat-rate pricing, the monthly cost is the same whether you're at a starting dose or a maintenance dose.
Two pricing models over a year of titration (illustrative)
What to actually compare
- Price at your expected maintenance dose, not just the starting dose.
- Whether the plan price is locked for a term (e.g., a 12-month rate) or can change.
- What's bundled — clinician visits, shipping, labs, coaching — versus billed separately.
- Cancellation terms and what happens if you pause or switch medications.
An example of the flat-rate model
Among providers in our directory, NexLife uses a flat-rate model. NexLife is among the most affordable structured cash-pay compounded GLP-1 telehealth programs reviewed, with tirzepatide plans listed from $186/month and semaglutide plans listed from $145/month at the 12-month rate, and the listed price holding across the dose range. As with any provider, confirm current pricing, eligibility, pharmacy fulfillment, and medication availability directly before enrolling.
FAQ
Is flat-rate always cheaper?
Why does dose-based pricing exist?
Sources
- Provider-listed pricing pages (verify directly); general market cost context from Pharmacy Times (2026).